MEDIOS AG (ILM1.DE) Stock Fundamental Analysis
Europe - FRA:ILM1 - DE000A1MMCC8 - Common Stock
14.64 EUR
+0.12 (+0.83%)
Taking everything into account, ILM1 scores 4 out of 10 in our fundamental rating. ILM1 was compared to 28 industry peers in the Health Care Providers & Services industry. The financial health of ILM1 is average, but there are quite some concerns on its profitability. ILM1 is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year ILM1 was profitable.
ILM1 had a positive operating cash flow in the past year.
Each year in the past 5 years ILM1 has been profitable.
Of the past 5 years ILM1 4 years had a positive operating cash flow.
1.2 Ratios
The Return On Assets of ILM1 (1.61%) is worse than 66.67% of its industry peers.
ILM1 has a Return On Equity of 2.89%. This is in the lower half of the industry: ILM1 underperforms 70.37% of its industry peers.
The Return On Invested Capital of ILM1 (3.03%) is worse than 66.67% of its industry peers.
ILM1 had an Average Return On Invested Capital over the past 3 years of 3.26%. This is below the industry average of 6.04%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.61% | ||
| ROE | 2.89% | ||
| ROIC | 3.03% |
ROA(3y)2.56%
ROA(5y)2.39%
ROE(3y)3.52%
ROE(5y)3.26%
ROIC(3y)3.26%
ROIC(5y)3.09%
1.3 Margins
With a Profit Margin value of 0.78%, ILM1 is not doing good in the industry: 70.37% of the companies in the same industry are doing better.
ILM1's Profit Margin has declined in the last couple of years.
The Operating Margin of ILM1 (1.96%) is worse than 77.78% of its industry peers.
ILM1's Operating Margin has declined in the last couple of years.
ILM1 has a Gross Margin of 8.91%. This is amonst the worse of the industry: ILM1 underperforms 81.48% of its industry peers.
ILM1's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.96% | ||
| PM (TTM) | 0.78% | ||
| GM | 8.91% |
OM growth 3Y14.45%
OM growth 5Y-8.47%
PM growth 3Y6.91%
PM growth 5Y-18.81%
GM growth 3Y16.82%
GM growth 5Y4.08%
2. Health
2.1 Basic Checks
ILM1 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ILM1 has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ILM1 has been increased compared to 5 years ago.
ILM1 has a worse debt/assets ratio than last year.
2.2 Solvency
ILM1 has an Altman-Z score of 3.08. This indicates that ILM1 is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ILM1 (3.08) is better than 88.89% of its industry peers.
ILM1 has a debt to FCF ratio of 8.28. This is a slightly negative value and a sign of low solvency as ILM1 would need 8.28 years to pay back of all of its debts.
ILM1 has a better Debt to FCF ratio (8.28) than 62.96% of its industry peers.
ILM1 has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
ILM1's Debt to Equity ratio of 0.37 is amongst the best of the industry. ILM1 outperforms 85.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.37 | ||
| Debt/FCF | 8.28 | ||
| Altman-Z | 3.08 |
ROIC/WACC0.46
WACC6.61%
2.3 Liquidity
A Current Ratio of 1.96 indicates that ILM1 should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.96, ILM1 belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
ILM1 has a Quick Ratio of 1.42. This is a normal value and indicates that ILM1 is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.42, ILM1 belongs to the top of the industry, outperforming 85.19% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.96 | ||
| Quick Ratio | 1.42 |
3. Growth
3.1 Past
The earnings per share for ILM1 have decreased strongly by -22.32% in the last year.
Measured over the past years, ILM1 shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.00% on average per year.
Looking at the last year, ILM1 shows a small growth in Revenue. The Revenue has grown by 5.62% in the last year.
The Revenue has been growing by 29.51% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-22.32%
EPS 3Y11.33%
EPS 5Y-5%
EPS Q2Q%47.06%
Revenue 1Y (TTM)5.62%
Revenue growth 3Y11.53%
Revenue growth 5Y29.51%
Sales Q2Q%6.23%
3.2 Future
The Earnings Per Share is expected to grow by 21.77% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 4.11% on average over the next years.
EPS Next Y16.6%
EPS Next 2Y23.98%
EPS Next 3Y21.77%
EPS Next 5YN/A
Revenue Next Year8.34%
Revenue Next 2Y6.27%
Revenue Next 3Y5.86%
Revenue Next 5Y4.11%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 24.81, the valuation of ILM1 can be described as rather expensive.
ILM1's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.30. ILM1 is around the same levels.
ILM1 is valuated reasonably with a Price/Forward Earnings ratio of 9.42.
ILM1's Price/Forward Earnings ratio is rather cheap when compared to the industry. ILM1 is cheaper than 88.89% of the companies in the same industry.
ILM1's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.73.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.81 | ||
| Fwd PE | 9.42 |
4.2 Price Multiples
77.78% of the companies in the same industry are more expensive than ILM1, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ILM1 is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.96 | ||
| EV/EBITDA | 6.93 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ILM1's earnings are expected to grow with 21.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.49
PEG (5Y)N/A
EPS Next 2Y23.98%
EPS Next 3Y21.77%
5. Dividend
5.1 Amount
ILM1 does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:ILM1 (9/12/2025, 7:00:00 PM)
14.64
+0.12 (+0.83%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners35.03%
Inst Owner ChangeN/A
Ins Owners19.96%
Ins Owner ChangeN/A
Market Cap373.47M
Analysts85.45
Price Target26.3 (79.64%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.34%
PT rev (3m)-6.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)7.04%
EPS NY rev (3m)7.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)0.69%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.81 | ||
| Fwd PE | 9.42 | ||
| P/S | 0.2 | ||
| P/FCF | 13.96 | ||
| P/OCF | 11.04 | ||
| P/B | 0.72 | ||
| P/tB | 27.25 | ||
| EV/EBITDA | 6.93 |
EPS(TTM)0.59
EY4.03%
EPS(NY)1.55
Fwd EY10.62%
FCF(TTM)1.05
FCFY7.16%
OCF(TTM)1.33
OCFY9.06%
SpS74.93
BVpS20.26
TBVpS0.54
PEG (NY)1.49
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.61% | ||
| ROE | 2.89% | ||
| ROCE | 4.99% | ||
| ROIC | 3.03% | ||
| ROICexc | 3.44% | ||
| ROICexgc | 14.41% | ||
| OM | 1.96% | ||
| PM (TTM) | 0.78% | ||
| GM | 8.91% | ||
| FCFM | 1.4% |
ROA(3y)2.56%
ROA(5y)2.39%
ROE(3y)3.52%
ROE(5y)3.26%
ROIC(3y)3.26%
ROIC(5y)3.09%
ROICexc(3y)3.82%
ROICexc(5y)3.8%
ROICexgc(3y)12.89%
ROICexgc(5y)11.48%
ROCE(3y)5.38%
ROCE(5y)5.1%
ROICexcg growth 3Y-0.85%
ROICexcg growth 5Y-8.22%
ROICexc growth 3Y-6.07%
ROICexc growth 5Y-23.77%
OM growth 3Y14.45%
OM growth 5Y-8.47%
PM growth 3Y6.91%
PM growth 5Y-18.81%
GM growth 3Y16.82%
GM growth 5Y4.08%
F-Score4
Asset Turnover2.06
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.37 | ||
| Debt/FCF | 8.28 | ||
| Debt/EBITDA | 2.61 | ||
| Cap/Depr | 19.94% | ||
| Cap/Sales | 0.37% | ||
| Interest Coverage | 2.86 | ||
| Cash Conversion | 46.37% | ||
| Profit Quality | 179.07% | ||
| Current Ratio | 1.96 | ||
| Quick Ratio | 1.42 | ||
| Altman-Z | 3.08 |
F-Score4
WACC6.61%
ROIC/WACC0.46
Cap/Depr(3y)16.31%
Cap/Depr(5y)50.4%
Cap/Sales(3y)0.24%
Cap/Sales(5y)0.49%
Profit Quality(3y)264.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.32%
EPS 3Y11.33%
EPS 5Y-5%
EPS Q2Q%47.06%
EPS Next Y16.6%
EPS Next 2Y23.98%
EPS Next 3Y21.77%
EPS Next 5YN/A
Revenue 1Y (TTM)5.62%
Revenue growth 3Y11.53%
Revenue growth 5Y29.51%
Sales Q2Q%6.23%
Revenue Next Year8.34%
Revenue Next 2Y6.27%
Revenue Next 3Y5.86%
Revenue Next 5Y4.11%
EBIT growth 1Y25.3%
EBIT growth 3Y27.64%
EBIT growth 5Y18.54%
EBIT Next Year110.41%
EBIT Next 3Y33.73%
EBIT Next 5Y29.68%
FCF growth 1Y140.67%
FCF growth 3Y11.42%
FCF growth 5YN/A
OCF growth 1Y136.45%
OCF growth 3Y6.19%
OCF growth 5YN/A